sontilen 5mcg ml injekční infuzní roztok - etsinnän tulokset

kamada ltd, israel - anti-d immunoglobulins - תמיסה להזרקה - anti-d immunoglobulins 150 mcg/ml - anti-d (rh) immunoglobulin - anti-d (rh) immunoglobulin - pregnancy/other obstetric conditions, suppression of rh immunization in non-sensitized rh0 (d) negative women delivering an rh0 positive baby or when the baby's rh type is unknown. suppression of rh immunization after spontaneous or induced abortions threatened abortion associated with maternal bleeding amniocentesis chorionic villus sampling ruptured tubal pregnancy and significant abdominal trauma. kam rh0 -d im should be given within 72 hours of the event. it may be given even after up to one month although efficacy may be somewhat reduced.transfusion: suppression of rh isoimmunization in rh0 (d) antigen-negative patients transfused with rh0 (d) antigen-positive rbcs of blood components containing rh0 (d) antigen-positive rbcs . initate treatment within 72 hours of exposure.

Israel - heprea - Ministry of Health

פרואבניר

bioavenir ltd, israel - finasteride - טבליות מצופות פילם - finasteride 1 mg - finasteride - finasteride - proavenir is indicated for the treatment of men with male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss.

Israel - heprea - Ministry of Health

קסנזין 25 מ"ג

megapharm ltd - tetrabenazine 25 mg - tablets - tetrabenazine - movement disorders, associated with organic central nervous system conditions, e.g. huntington's chorea, hemiballismus and senile chorea.moderate to severe tardive dyskinesia, which is disabling and/or socially embanassing. the condition should be persistent despite a switch to atypical antipsychotic medication and/or reduction in dosage of antipsychotic medication, when withdrawal of antipsychotic medication is not a realistic option.